Disruption of blood brain barrier in Alzheimer disease pathogenesis

Tissue Barriers

Volumn 1, Issue 2, 2013, Pages

  Kook, Sun Young ^a   Hong, Hyun Seok ^a,b   Moon, Minho ^a   Mook Jung, Inhee ^a  

^a Seoul National University   (South Korea)

^b Medifron DBT   (South Korea)

Author keywords

Alzheimer disease; Amyloidbeta peptide; Blood brain barrier; Calcium; RAGE; Tight junction associated protein

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID PRECURSOR PROTEIN; CALCINEURIN; ILOMASTAT; LOW DENSITY LIPOPROTEIN RECEPTOR; MATRIX METALLOPROTEINASE; OCCLUDIN; TACROLIMUS;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CALCIUM TRANSPORT; CELL DEATH; CONFOCAL MICROSCOPY; NONHUMAN; NOTE; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SINGLE DRUG DOSE; TIGHT JUNCTION; TRANSCYTOSIS; VASCULAR AMYLOIDOSIS;

ANIMALIA; MUS;

EID: 84907598922     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.153/jneurosci.601211     Document Type: Note

References (30)

1. Nagy ZS, Esiri MM, Joachim C, Jobst KA, Morris JH, King EM, et al. Comparison of pathological diagnostic criteria for Alzheimer disease. Alzheimer Dis Assoc Disord 1998; 12:182-9; PMID:9772021; http://dx.doi.org/10.1097/00002093-199809000-00010.
2. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology 1996; 46:1592-6; PMID:8649554; http://dx.doi. org/10.1212/WNL.46.6.1592.
3. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81:741-66; PMID:11274343.
4. Claudio L. Ultrastructural features of the bloodbrain barrier in biopsy tissue from Alzheimer's disease patients. Acta Neuropathol 1996; 91:6-14; PMID:8773140; http://dx.doi.org/10.1007/ s004010050386.
5. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998; 51:159-62; PMID:9674796; http:// dx.doi.org/10.1212/WNL.51.1.159.
6. Abbott NJ, Rönnbäck L, Hansson E. Astrocyteendothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7:41-53; PMID:16371949; http://dx.doi.org/10.1038/nrn1824.
7. Watson PM, Anderson JM, Vanltallie CM, Doctrow SR. The tight-junction-specific protein ZO-1 is a component of the human and rat blood-brain barriers. Neurosci Lett 1991; 129:6-10; PMID:1922971; http://dx.doi.org/10.1016/0304-3940(91)90708-2.
8. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 1998; 273:29745-53; PMID:9792688; http://dx.doi.org/10.1074/ jbc.273.45.29745.
9. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996; 382:685-91; PMID:8751438; http://dx.doi. org/10.1038/382685a0.
10. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, et al. RAGE mediates amyloidbeta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003; 9:907-13; PMID:12808450; http://dx.doi.org/10.1038/ nm890.
11. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptorrelated protein-1 at the blood-brain barrier. J Clin Invest 2000; 106:1489-99; PMID:11120756; http:// dx.doi.org/10.1172/JCI10498.
12. Matsubara E, Ghiso J, Frangione B, Amari M, Tomidokoro Y, Ikeda Y, et al. Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome. Ann Neurol 1999; 45:537-41; PMID:10211483; http://dx.doi.org/10.1002/1531-8249(199904)45:4<537::AID-ANA20>3.0.CO;2-2.
13. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 2001; 21:372-81; PMID:11160418.
14. Kawahara M, Kuroda Y, Arispe N, Rojas E. Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J Biol Chem 2000; 275:14077-83; PMID:10799482; http:// dx.doi.org/10.1074/jbc.275.19.14077.
15. Kagan BL, Hirakura Y, Azimov R, Azimova R, Lin MC. The channel hypothesis of Alzheimer's disease: current status. Peptides 2002; 23:1311-5; PMID:12128087; http://dx.doi.org/10.1016/S0196-9781(02)00067-0.
16. Bond M, Fabunmi RP, Baker AH, Newby AC. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 1998; 435:29-34; PMID:9755853; http:// dx.doi.org/10.1016/S0014-5793(98)01034-5.
17. Stuart RO, Sun A, Bush KT, Nigam SK. Dependence of epithelial intercellular junction biogenesis on thapsigargin-sensitive intracellular calcium stores. J Biol Chem 1996; 271:13636-41; PMID:8662885; http://dx.doi.org/10.1074/jbc.271.23.13636.
18. Cho HJ, Son SM, Jin SM, Hong HS, Shin DH, Kim SJ, et al. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model. FASEB J 2009; 23:2639-49; PMID:19332646; http://dx.doi.org/10.1096/fj.08-126383.
19. Miravalle L, Tokuda T, Chiarle R, Giaccone G, Bugiani O, Tagliavini F, et al. Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem 2000; 275:27110-6; PMID:10821838.
20. Folin M, Baiguera S, Tommasini M, Guidolin D, Conconi MT, De Carlo E, et al. Effects of betaamyloid on rat neuromicrovascular endothelial cells cultured in vitro. Int J Mol Med 2005; 15:929-35; PMID:15870895.
21. Restituito S, Khatri L, Ninan I, Mathews PM, Liu X, Weinberg RJ, et al. Synaptic autoregulation by metalloproteases and γ-secretase. J Neurosci 2011; 31:12083-93; PMID:21865451; http://dx.doi. org/10.1523/JNEUROSCI.2513-11.2011.
22. Hong HS, Hwang JY, Son SM, Kim YH, Moon M, Inhee MJ. FK506 reduces amyloid plaque burden and induces MMP-9 in AβPP/PS1 double transgenic mice. J Alzheimers Dis 2010; 22:97-105; PMID:20847451.
23. Gonzalez-Mariscal L, Contreras RG, Bolívar JJ, Ponce A, Chávez De Ramirez B, Cereijido M. Role of calcium in tight junction formation between epithelial cells. Am J Physiol 1990; 259:C978-86; PMID:2124417.
24. Liu F, Grundke-Iqbal I, Iqbal K, Oda Y, Tomizawa K, Gong CX. Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem 2005; 280:37755-62; PMID:16150694; http://dx.doi.org/10.1074/jbc.M507475200.
25. Agostinho P, Lopes JP, Velez Z, Oliveira CR. Overactivation of calcineurin induced by amyloidbeta and prion proteins. Neurochem Int 2008; 52:1226-33; PMID:18295934; http://dx.doi. org/10.1016/j.neuint.2008.01.005.
26. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12:376-89; PMID:1346802.
27. Simm A, Casselmann C, Schubert A, Hofmann S, Reimann A, Silber RE. Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction. Exp Gerontol 2004; 39:407-13; PMID:15036400; http://dx.doi.org/10.1016/j.exger.2003.12.006.
28. Li M, Shang DS, Zhao WD, Tian L, Li B, Fang WG, et al. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J Immunol 2009; 182:5778-88; PMID:19380826; http://dx.doi. org/10.4049/jimmunol.0803013.
29. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006; 26:10129-40; PMID:17021169; http://dx.doi. org/10.1523/JNEUROSCI.1202-06.2006.
30. Garcia-Alloza M, Prada C, Lattarulo C, Fine S, Borrelli LA, Betensky R, et al. Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. J Neurochem 2009; 109:1636-47; PMID:19457117; http://dx.doi.org/10.1111/j.1471-4159.2009.06096.x.